Dáil Éireann Debate, Tuesday - 12 October 2021
617. Deputy Catherine Connolly asked the Minister for Health further to Parliamentary Question No. 678 of 15 September 2021, the status of the establishment of a stakeholder group to address ongoing concerns relating to the use of sodium valproate; the membership of the stakeholder group; when he expects the stakeholder group to be up and running; and if he will make a statement on the matter. [49698/21]
View answer628. Deputy Darren O'Rourke asked the Minister for Health the status of the establishment of a stakeholder group to collaboratively assess and strengthen the risk reduction measures currently associated with the prescribing and dispensing of sodium valproate in women of child-bearing potential as agreed in November 2020; and if he will make a statement on the matter. [49769/21]
View answerI propose to take Questions Nos. 617 and 628 together.
Details of the proposed stakeholder group referred to by the Deputy are currently under consideration by officials within the Department of Health.
